Practice-Changing Trial in Prostate Cancer Shows Benefits of Perioperative Therapy

(MedPage Today) — CHICAGO — A paradigm-changing clinical trial in prostate cancer showed that perioperative apalutamide (Erleada) and androgen deprivation therapy (ADT) significantly reduced the risk of metastasis in high-risk localized disease…